Countdown to Mumbai: TAPI is Ready to Focus on Developing Markets
By Pooja Chavan, TAPI Sales & Marketing, Mumbai, India
The Bombay Exhibition Center will be buzzing next month when CPhI India comes to Mumbai, and TAPI can't wait to be part of the excitement! This event means a great opportunity to the TAPI team, as it enables us to spend time with our customers in India and other developed markets, many who travel long distances to be there.
Our team will be there to greet you throughout the three-day event. We invite customers to stop by anytime, and we look forward to understanding how we can support you with solutions or advise on your needs.
TAPI customers come first in everything we do and CPhI India will be no exception. This year our booth highlights the customer journey and the many solutions and ways TAPI's global team supports customers throughout every touchpoint in the product lifecycle – from selection to commercial.
Gil Feldman, our head of sales for the Asia Pacific Markets, will lead our 11 member team and is looking forward to welcoming you and learning what we can do to make your customer experience even better. Gil brings his vast experience and expertise from more than seven years at Teva and TAPI in different positions and markets, including serving as acting head of our sales organization in Japan and Korea and spending three years in our North America office.
Introducing new APIs and exciting new capabilities
TAPI continually looks for opportunities to expand our products and services so customers can retain their competitive edge. We're pleased to give customers at CPhI India a preview of six new products with preliminary launch dates in 2030 and beyond. They include:
Coming soon – new capabilities to support API sterilization
TAPI is building a new facility designed specifically to provide API sterilization services for TAPI's APIs, as well as third-party APIs. Customers who need API sterilization will soon be able to rely on TAPI to fulfill that need for a wide range of molecules and both small and large production volumes.
We invite you to drop by to discuss our new API Sterilization service.
TAPI Online, our first-in-class customer platform which was introduced last year, continues to add useful tools and new resources. More than 2,000 customers worldwide access it regularly to find essential product information and documentation. Ask for a live demo and sign up for an account during the show.
TAPI experts will be available to answer your questions about R&D, our regulatory affairs support, and the advice and assistance we can provide for customers who are looking to penetrate specific markets.
Interested in learning more about new products or our sterile API plans? Please visit us at CPhI India, Hall 1 Stand G71 or inquire now!
Exciting changes are taking place in India and Southeast Asia's pharmaceutical markets, and TAPI has the resources and expertise to help customers stay ahead of the curve. We hope you'll join us during CPhI India to discover the many ways we can support your needs.
TAPI will see you at CPhI India: 28-30 November, Bombay Exhibition Center, Hall 1, Stand G71!
Pooja Chavan, TAPI Sales and Marketing based in Mumbai, has spent the past six years responsible for market intelligence for India, and countries throughout the Asia Pacific and Latin America.
- If you are attending CPhI India and would like to schedule a meeting, please contact your account manager or fill in this contact form!
- Are you interested in more information, or samples of TAPI's new or existing products? Please let us know if you would like to discuss future product plans at the event.
- Would you like to learn more about TAPI's plans to produce sterile APIs? Inquire now
- Are there new or different ways TAPI can help you meet your production goals? Can we provide additional technical services or customer support? let us know
Neither the introduction of such products, nor any reference herein to these or any other products, projects or services shall constitute an offer for sale, or be construed as representing an offer for sale. In particular, nothing herein should be construed as a promotion or advertisement for any product, or for the use of any product, that infringes valid patents and/or is not authorized by the laws and regulations of any country or other jurisdiction.